These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3983219)

  • 21. Quantitation of tolerance development after chronic oxotremorine treatment.
    Marks MJ; Artman LD; Collins AC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):103-13. PubMed ID: 6622504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype influences the development of tolerance to nicotine in the mouse.
    Marks MJ; Campbell SM; Romm E; Collins AC
    J Pharmacol Exp Ther; 1991 Oct; 259(1):392-402. PubMed ID: 1920127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
    Marks MJ; Collins AC
    Mol Pharmacol; 1982 Nov; 22(3):554-64. PubMed ID: 7155123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment.
    Pauly JR; Marks MJ; Gross SD; Collins AC
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1127-36. PubMed ID: 1890617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors.
    Collins AC; Romm E; Wehner JM
    Brain Res Bull; 1990 Sep; 25(3):373-9. PubMed ID: 2292034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice.
    Collins AC; Romm E; Selvaag S; Turner S; Marks MJ
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1390-7. PubMed ID: 8371144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of muscarinic and nicotinic receptors by cholinergic stimulation in cultured avian retina cells.
    Siman RG; Klein WL
    Brain Res; 1983 Feb; 262(1):99-108. PubMed ID: 6831232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An autoradiographic analysis of cholinergic receptors in mouse brain.
    Pauly JR; Stitzel JA; Marks MJ; Collins AC
    Brain Res Bull; 1989 Feb; 22(2):453-9. PubMed ID: 2706548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinergic adaptations to chronic oxotremorine infusion.
    Marks MJ; Artman LD; Patinkin DM; Collins AC
    J Pharmacol Exp Ther; 1981 Aug; 218(2):337-43. PubMed ID: 7252834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion.
    Collins AC; Luo Y; Selvaag S; Marks MJ
    J Pharmacol Exp Ther; 1994 Oct; 271(1):125-33. PubMed ID: 7965705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscarinic receptor alterations as a mechanism of anticholinesterase tolerance.
    Schwab BW; Costa LG; Murphy SD
    Toxicol Appl Pharmacol; 1983 Oct; 71(1):14-23. PubMed ID: 6636179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the development of tolerance to ethanol and cross-tolerance to nicotine after chronic ethanol treatment in long- and short-sleep mice.
    de Fiebre CM; Collins AC
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1398-406. PubMed ID: 8371145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of muscarinic receptors of bovine adrenal chromaffin cells: binding, secretion and anti-microtubule drug effects.
    McKay DB; Lopez I; Sanchez PA; English JL; Wallace LJ
    Gen Pharmacol; 1991; 22(6):1185-9. PubMed ID: 1810813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinociceptive effect of diisopropylphosphofluoridate: development of tolerance and lack of cross-tolerance to morphine.
    Costa LG; Murphy SD
    Neurobehav Toxicol Teratol; 1985; 7(3):251-6. PubMed ID: 2993935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine.
    el-Bizri H; Clarke PB
    Br J Pharmacol; 1994 Nov; 113(3):917-25. PubMed ID: 7858886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of DDT on muscarine- and nicotine-like binding sites in CNS of immature and adult mice.
    Eriksson P; Falkeborn Y; Nordberg A; Slanina P
    Toxicol Lett; 1984 Sep; 22(3):329-34. PubMed ID: 6485006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscarinic receptor alterations following neostigmine treatment.
    Costa LG; Schwab BW; Murphy SD
    Eur J Pharmacol; 1982 May; 80(2-3):275-8. PubMed ID: 7106184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors.
    Collins AC; Evans CB; Miner LL; Marks MJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1767-73. PubMed ID: 3737641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic scopolamine treatment and brain cholinergic function.
    Marks MJ; O'Connor MF; Artman LD; Burch JB; Collins AC
    Pharmacol Biochem Behav; 1984 May; 20(5):771-7. PubMed ID: 6739517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors.
    Marks MJ; Burch JB; Collins AC
    J Pharmacol Exp Ther; 1983 Sep; 226(3):817-25. PubMed ID: 6887012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.